Please login to the form below

Not currently logged in
Email:
Password:

Novocure’s chief commercial officer to step down

Peter Melnyk will leave the oncology specialist on 15 March

Novocure Peter MelnykPeter Melnyk, Novocure's chief commercial officer is set to step down from 15 March this year.

Melnyk joined the oncology specialist in 2011, taking on responsibility for its global marketing and sales efforts.

Previously, he was senior vice president for sales and marketing at OSI Pharmaceuticals, where he led the global commercialisation of Tarceva (erlotinib) from 2003 to 2011.

Prior to this, Melnyk served as executive director of oncology at Pfizer and a director of oncology at Bristol-Myers Squibb.

Asaf Danziger, Novocure's chief executive officer, said: “I want to thank Peter for his more than five years of leadership at Novocure.

“During his tenure, Peter developed our commercial business model, launched the Optune brand and drove eight consecutive quarters of active patient and revenue growth after the presentation of our EF-14 clinical data in Q4 2014.

“Peter leaving our commercial organisation in a strong position to continue its success. I look forward to following Peter's continued accomplishments as he begins the next chapter of his career.”

7th March 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
Rare thoughts & outcomes - navigating pathways to better outcomes in rare
...
How to pick the perfect training program for your healthcare professionals
You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...